Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 3/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29953534 | 1.00 | ENPP2 (0.44) | ENPP2TSHRCLK4GSK3BDRD2 | |
| SCHEMBL1629915 | 0.84 | FBP1 (0.50) | MAOB | |
| SCHEMBL12230306 | 0.81 | FBP1 (0.48) | MAOB | |
| SCHEMBL11930766 | 0.81 | CLK4 (0.54) | TSHRCLK4ALDH1A1MAPTIDO1 | |
| SCHEMBL12271100 | 0.81 | ENPP2 (0.57) | ENPP2TSHRCLK4GSK3BDRD2 | |
| SCHEMBL12417362 | 0.81 | CLK4 (0.36) | ENPP2TSHRCLK4GSK3BDRD2 | |
| SCHEMBL28592899 | 0.80 | ENPP2 (0.45) | ENPP2TSHRCLK4GSK3BDRD2 | |
| SCHEMBL11930765 | 0.80 | CLK4 (0.53) | TSHRCLK4ALDH1A1MAPTIDO1 | |
| SCHEMBL13170987 | 0.78 | PGR (0.47) | CLK4ALDH1A1 | |
| SCHEMBL12408530 | 0.78 | TBXAS1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812660-B2 | Organic compound, electroluminescent material and application thereof | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-11793071-B2 | Organic compound, electroluminescent material, and use thereof | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-10-17 | — | — | US | disclosed |
| US-20230322673-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230322747-A1 | OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF | EIKONIZO THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230295449-A1 | COMPOSITION AND LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11739061-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11680053-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-06-20 | — | — | US | disclosed |
| US-20230189643-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230157150-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | LG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-11647671-B2 | Compound and organic electro-optical device containing the same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
| US-8383584-B2 | HCV inhibiting macrocyclic phenylcarbamates | MEDIVIR AB (SE) | 2013-02-26 | — | — | US | disclosed |
| US-20110129738-A1 | NONAQUEOUS ELECTROLYTE BATTERY | SONY CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| US-7811681-B2 | Electron transport compound and organic light emitting device comprising the same | LG DISPLAY CO., LTD. (KR) | 2010-10-12 | — | — | US | disclosed |
| US-20100072437-A1 | COMPOSITION, COLOR FILTER AND PROCESS FOR PREPARING COLOR FILTER | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20100041728-A1 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES | MEDIVIR AB | 2010-02-18 | — | — | US | disclosed |
| EP-2111396-A1 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES | Tibotec Pharmaceuticals Ltd. (IE) | 2009-10-28 | — | — | EP | disclosed |
| US-7595417-B2 | Cyanation of aromatic halides | MERCK & CO., INC. (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090130726-A1 | PROCESS FOR CONVERTING AROMATIC HALO-SUBSTITUTED DINITRILES INTO HALO-SUBSTITUTED CYANOCARBOXYLIC ACIDS | ASTRAZENECA AB (SE) | 2009-05-21 | — | — | US | disclosed |
| WO-2008096001-A1 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2008-08-14 | — | — | WO | disclosed |
| US-20070167626-A1 | Electron transport compound and organic light emitting device comprising the same | LG ELECTRONICS INC. | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322747-A1 | OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF | HDAC6, HDAC1, HDAC11 | ENPP2 3140/4885TSHR 4540/4885CLK4 3160/4885 |
| US-20070167626-A1 | Electron transport compound and organic light emitting device comprising the same | TIMM9, SLCO4C1, SLC25A21 | ENPP2 3545/4885TSHR 3970/4885CLK4 3650/4885 |
| US-20100041728-A1 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES | COPB1, HAVCR2, NOD1 | ENPP2 4296/4885TSHR 4776/4885CLK4 3839/4885 |
| US-11793071-B2 | Organic compound, electroluminescent material, and use thereof | LEF1, SLCO2A1, SLCO2B1 | ENPP2 2119/4885TSHR 4427/4885CLK4 2380/4885 |
| US-20230322673-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | L1CAM, CCNL2, CTNND1 | ENPP2 3094/4885TSHR 3827/4885CLK4 550/4885 |
| US-11812660-B2 | Organic compound, electroluminescent material and application thereof | MRPS22, RPS3A, MRPS23 | ENPP2 2324/4885TSHR 1949/4885CLK4 1077/4885 |
| US-11680053-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | GRM5, GRM2, GRM6 | ENPP2 938/4885TSHR 705/4885CLK4 2860/4885 |
| US-11647671-B2 | Compound and organic electro-optical device containing the same | EPCAM, LPO, CYBA | ENPP2 2490/4885TSHR 3745/4885CLK4 2938/4885 |
| US-11739061-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | L1CAM, CCNL2, CTNND1 | ENPP2 3094/4885TSHR 3827/4885CLK4 550/4885 |
| US-20230157150-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | OCIAD1, EML4, OCIAD2 | ENPP2 4230/4885TSHR 4772/4885CLK4 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.